0 NASDAQ Companies - July 10, 2024Aesthetic Medical International Holdings Group Ltd. Announces the Commencement of OTCQX TradingSHENZHEN, China, July 10, 2024 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (OTCQX: PAIYY) (the “Company” or “AIH”), […]Read More
0 NASDAQ Companies - July 10, 2024Eagle Bancorp Announces Earnings Call on July 25, 2024BETHESDA, Md., July 10, 2024 (GLOBE NEWSWIRE) — Eagle Bancorp, Inc., (the “Company”) (NASDAQ: EGBN), the parent company of EagleBank, […]Read More
0 NASDAQ Companies - July 10, 2024Colliers agrees partnership in Switzerland to strengthen European presence LONDON and ZURICH, July 10, 2024 (GLOBE NEWSWIRE) — Colliers, a leading diversified professional services and investment management company, is […]Read More
0 NASDAQ Companies - July 9, 2024Dime Community Bancshares, Inc. Announces Full Exercise of Underwriters’ Overallotment OptionHAUPPAUGE, N.Y., July 09, 2024 (GLOBE NEWSWIRE) — Dime Community Bancshares, Inc. (the “Company”) (NASDAQ: “DCOM”), the parent company of […]Read More
0 NASDAQ Companies - July 9, 2024NorthWestern to Host Second Quarter 2024 Financial Results WebinarBUTTE, Mont. and SIOUX FALLS, S.D., July 09, 2024 (GLOBE NEWSWIRE) — NorthWestern Energy Group, Inc. d/b/a NorthWestern Energy (Nasdaq: […]Read More
0 NASDAQ Companies - July 9, 2024SIM Acquisition Corp. I Announces the Pricing of $200,000,000 Initial Public OfferingNEW YORK, July 09, 2024 (GLOBE NEWSWIRE) — SIM Acquisition Corp. I (the “Company”) announced today the pricing of its […]Read More
0 NASDAQ Companies - July 9, 2024Teknova Provides Strategic Business Update and Announces Preliminary Second Quarter 2024 ResultsSecond quarter 2024 total revenue is in the range of $9.4 to $9.6 million Company reaffirms 2024 revenue guidance of […]Read More
0 NASDAQ Companies - July 9, 2024FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of AgeZORYVE cream provides rapid relief, with efficacy, safety, and tolerability demonstrated up to 56 weeks of treatment ZORYVE cream rapidly […]Read More
0 NASDAQ Companies - July 9, 2024Certara to Acquire Chemaxon to Strengthen Drug Discovery Software PortfolioCombined organization brings broader predictive capabilities to drug discovery at scale Reiterates full year 2024 guidance RADNOR, Pa., July 09, […]Read More
0 NASDAQ Companies - July 9, 2024LegalZoom Announces Leadership TransitionCurrent Chairman Jeffrey Stibel to become next CEO John Murphy named Lead Independent Director MOUNTAIN VIEW, Calif., July 09, 2024 […]Read More